884 Matching Annotations
  1. Jun 2021
    1. Knock, E. S., Whittles, L. K., Lees, J. A., Perez-Guzman, P. N., Verity, R., FitzJohn, R. G., Gaythorpe, K. A. M., Imai, N., Hinsley, W., Okell, L. C., Rosello, A., Kantas, N., Walters, C. E., Bhatia, S., Watson, O. J., Whittaker, C., Cattarino, L., Boonyasiri, A., Djaafara, B. A., … Baguelin, M. (2021). Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England. Science Translational Medicine, eabg4262. https://doi.org/10.1126/scitranslmed.abg4262

    1. Anne: That’s really tragic, and I'm hoping that you'll be able to soon go over. But sort of leading up to all that, so when you crossed the border, did you end up living in Arizona?Mike: Yes. I remember the first place I got to was Tucson. We had gone to Taco Bell. I love Taco Bell. That's why I love Taco Bell. I remember that now. I was like, "Damn, why do I like Taco Bell?" But yeah, I remember I came in a Taco Bell and I had thorns from the cactus stuck in my feet and I remember they got infected.Mike: All this green and pus was coming out and a lady from the Taco Bell gave us some food, and let us stay with her. Really good people too. I remember that every time I think about that. But we started living with them and then we started getting side jobs here and there. There was also a point in time where my dad and my mom really didn't get along.

      Time in the US, Arriving in the United States, First impressions, Living situation

  2. May 2021
    1. Dr Ellie Murray. (2021, May 7). I’m seeing a lot of “these people are over-estimating risk” chatter that doesn’t acknowledge that the probability you die if you get covid is always less than the probability anyone dies if you get covid. It’s not “over-estimation” to consider community impacts. [Tweet]. @EpiEllie. https://twitter.com/EpiEllie/status/1390792624777334797

    2. Prof. Christina Pagel. (2021, May 17). this is important because it means that lab based studies looking at this tell you meaningful things about real world efficacy—And the lab based studies are much quicker than real world ones. [Tweet]. @chrischirp. https://twitter.com/chrischirp/status/1394276693335019525

    1. Chavarria-Miró, G., Anfruns-Estrada, E., Guix, S., Paraira, M., Galofré, B., Sáanchez, G., Pintó, R., & Bosch, A. (2020). Sentinel surveillance of SARS-CoV-2 in wastewater anticipates the occurrence of COVID-19 cases. MedRxiv, 2020.06.13.20129627. https://doi.org/10.1101/2020.06.13.20129627

    1. Poletti, P., Tirani, M., Cereda, D., Trentini, F., Guzzetta, G., Marziano, V., Buoro, S., Riboli, S., Crottogini, L., Piccarreta, R., Piatti, A., Grasselli, G., Melegaro, A., Gramegna, M., Ajelli, M., & Merler, S. (2020). Infection fatality ratio of SARS-CoV-2 in Italy. ArXiv:2007.04381 [q-Bio]. http://arxiv.org/abs/2007.04381

    1. Hall, V. J., Foulkes, S., Saei, A., Andrews, N., Oguti, B., Charlett, A., Wellington, E., Stowe, J., Gillson, N., Atti, A., Islam, J., Karagiannis, I., Munro, K., Khawam, J., Chand, M. A., Brown, C. S., Ramsay, M., Lopez-Bernal, J., Hopkins, S., … Heeney, J. L. (2021). COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): A prospective, multicentre, cohort study. The Lancet, 0(0). https://doi.org/10.1016/S0140-6736(21)00790-X

    1. Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D. da S., Mishra, S., Crispim, M. A. E., Sales, F. C. S., Hawryluk, I., McCrone, J. T., Hulswit, R. J. G., Franco, L. A. M., Ramundo, M. S., Jesus, J. G. de, Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C. A. M., Manuli, E. R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science. https://doi.org/10.1126/science.abh2644

    1. Chen, X., Chen, Z., Azman, A. S., Deng, X., Sun, R., Zhao, Z., Zheng, N., Chen, X., Lu, W., Zhuang, T., Yang, J., Viboud, C., Ajelli, M., Leung, D. T., & Yu, H. (2021). Serological evidence of human infection with SARS-CoV-2: A systematic review and meta-analysis. The Lancet Global Health, 0(0). https://doi.org/10.1016/S2214-109X(21)00026-7

  3. Apr 2021
    1. Graham, M. S., Sudre, C. H., May, A., Antonelli, M., Murray, B., Varsavsky, T., Kläser, K., Canas, L. S., Molteni, E., Modat, M., Drew, D. A., Nguyen, L. H., Polidori, L., Selvachandran, S., Hu, C., Capdevila, J., Koshy, C., Ash, A., Wise, E., … Ourselin, S. (2021). Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: An ecological study. The Lancet Public Health, 0(0). https://doi.org/10.1016/S2468-2667(21)00055-4

    1. Dr Lea Merone MBChB (hons) MPH&TM MSc FAFPHM Ⓥ. ‘I’m an Introvert and Being Thrust into the Centre of This Controversy Has Been Quite Confronting. I’ve Had a Little Processing Time Right Now and I Have a Few Things to Say. I Won’t Repeat @GidMK and His Wonderful Thread but I Will Say 1 This Slander of Us Both Has Been 1/n’. Tweet. @LeaMerone (blog), 29 March 2021. https://twitter.com/LeaMerone/status/1376365651892166658.

  4. Mar 2021
    1. de Oliveira T, Lutucuta S, Nkengasong J, Morais J, Paixao JP, Neto Z, Afonso P, Miranda J, David K, Ingles L, Amilton P A P R R C, Freitas H R, Mufinda F, Tessema K S , Tegally H, San E J, Wilkinson E, Giandhari J, Pillay S, Giovanetti M, Naidoo Y, Katzourakis A, Ghafari M, Singh L, Tshiabuila D, Martin D, Lessells R. (2021) A Novel Variant of Interest of SARS-CoV-2 with Multiple Spike Mutations Detected through Travel Surveillance in Africa. medRxiv. https://www.krisp.org.za/publications.php?pubid=330. Accessed 26 March 2021.

    1. Larremore, D. B., Wilder, B., Lester, E., Shehata, S., Burke, J. M., Hay, J. A., Tambe, M., Mina, M. J., & Parker, R. (2020). Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance. MedRxiv, 2020.06.22.20136309. https://doi.org/10.1101/2020.06.22.20136309

    1. O’Driscoll, M., Santos, G. R. D., Wang, L., Cummings, D. A. T., Azman, A. S., Paireau, J., Fontanet, A., Cauchemez, S., & Salje, H. (2020). Age-specific mortality and immunity patterns of SARS-CoV-2 infection in 45 countries. MedRxiv, 2020.08.24.20180851. https://doi.org/10.1101/2020.08.24.20180851

    1. Damialis, A., Gilles, S., Sofiev, M., Sofieva, V., Kolek, F., Bayr, D., Plaza, M. P., Leier-Wirtz, V., Kaschuba, S., Ziska, L. H., Bielory, L., Makra, L., Trigo, M. del M., Group, C.-19/POLLEN study, & Traidl-Hoffmann, C. (2021). Higher airborne pollen concentrations correlated with increased SARS-CoV-2 infection rates, as evidenced from 31 countries across the globe. Proceedings of the National Academy of Sciences, 118(12). https://doi.org/10.1073/pnas.2019034118

  5. Feb 2021
    1. Pastor-Barriuso, R., Pérez-Gómez, B., Hernán, M. A., Pérez-Olmeda, M., Yotti, R., Oteo-Iglesias, J., Sanmartín, J. L., León-Gómez, I., Fernández-García, A., Fernández-Navarro, P., Cruz, I., Martín, M., Delgado-Sanz, C., Larrea, N. F. de, Paniagua, J. L., Muñoz-Montalvo, J. F., Blanco, F., Larrauri, A., & Pollán, M. (2020). Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: Nationwide seroepidemiological study. BMJ, 371, m4509. https://doi.org/10.1136/bmj.m4509

    1. Dr Ellie Murray. (2020, December 3). Some really great resources & discussions in this thread. The tl;dr is (1) yes, the vaccine trials included some people who had previously had COVID; and (2) in general vaccination plans will include those who have previously been sick/infected. Thanks all! [Tweet]. @EpiEllie. https://twitter.com/EpiEllie/status/1334545373126389766

    1. Aknin, L., Neve, J.-E. D., Dunn, E., Fancourt, D., Goldberg, E., Helliwell, J., Jones, S. P., Karam, E., Layard, R., Lyubomirsky, S., Rzepa, A., Saxena, S., Thornton, E., VanderWeele, T., Whillans, A., Zaki, J., Caman, O. K., & Amour, Y. B. (2021). A Review and Response to the Early Mental Health and Neurological Consequences of the COVID-19 Pandemic. PsyArXiv. https://doi.org/10.31234/osf.io/zw93g

    1. Hodcroft, E. B., Domman, D. B., Oguntuyo, K., Snyder, D. J., Diest, M. V., Densmore, K. H., Schwalm, K. C., Femling, J., Carroll, J. L., Scott, R. S., Whyte, M. M., Edwards, M. D., Hull, N. C., Kevil, C. G., Vanchiere, J. A., Lee, B., Dinwiddie, D. L., Cooper, V. S., & Kamil, J. P. (2021). Emergence in late 2020 of multiple lineages of SARS-CoV-2 Spike protein variants affecting amino acid position 677. MedRxiv, 2021.02.12.21251658. https://doi.org/10.1101/2021.02.12.21251658

    1. Shen, X., Tang, H., McDanal, C., Wagh, K., Fischer, W. M., Theiler, J., Yoon, H., Li, D., Haynes, B. F., Saunders, K. O., Gnanakaran, S., Hengartner, N. W., Pajon, R., Smith, G., Dubovsky, F., Glenn, G. M., Korber, B. T., & Montefiori, D. C. (2021). SARS-CoV-2 Variant B.1.1.7 is Susceptible to Neutralizing Antibodies Elicited by Ancestral Spike Vaccines (SSRN Scholarly Paper ID 3777473). Social Science Research Network. https://papers.ssrn.com/abstract=3777473

  6. Jan 2021
    1. ReconfigBehSci. (2020, November 9). RT @peterbachmd: Relevant today: Ever sharp @nataliexdean on Vaccine Effectiveness vs Efficacy from many moons ago (i.e. About a month). Sh… [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1325889181097267200

  7. Dec 2020